Meta-analysis of 74 RCTs (over 29,000 patients) with skin IMIDs: JAK-STAT inhibitors vs placebo were associated with more influenza (RR 2.12), bronchitis (RR 2.03) and herpes zoster (RR 1.67), but not serious, fungal or opportunistic infections.
Meta-analysisn = 29,000
Krebs et al. Large-scale meta-analysis of infection risk with JAK-STAT inhibitors in 29,000 patients